Merit Medical Systems (MMSI) Liabilities and Shareholders Equity (2009 - 2026)

Merit Medical Systems' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $2.7 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 10.18% year-over-year to $2.7 billion; the TTM figure through Mar 2026 stood at $10.6 billion (up 10.23% YoY), while the FY2025 annual figure was $2.7 billion, up 11.05% from the prior year.
• Liabilities and Shareholders Equity came in at $2.7 billion for Q1 2026 at Merit Medical Systems, up from $2.7 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.7 billion in Q1 2026 to a low of $1.6 billion in Q1 2022.
• A 5-year average of $2.2 billion and a median of $2.3 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity retreated 1.33% in 2022 and jumped 39.74% in 2023, its largest moves.
• Merit Medical Systems' Liabilities and Shareholders Equity stood at $1.7 billion in 2022, then jumped by 39.74% to $2.3 billion in 2023, then increased by 4.02% to $2.4 billion in 2024, then climbed by 11.05% to $2.7 billion in 2025, then rose by 1.24% to $2.7 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.7 billion, $2.7 billion, and $2.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison